Previous 10 | Next 10 |
Gilead Sciences (NASDAQ: GILD) has been making waves of late. The company's antiviral drug, remdesivir, is currently perceived as the most promising potential treatment for COVID-19. As a result, Gilead's shares are up by 22% year to date, while the S&P 500 is down by 15% since the beg...
Galapagos NV (NASDAQ: GLPG ) and Ryvu Therapeutics announce a collaboration focused on the discovery and development of novel small molecule drugs in inflammation. More news on: Galapagos NV, Healthcare stocks news, Read more ...
MECHELEN, Belgium and KRAKOW, Poland , April 16, 2020 /PRNewswire/ -- Galapagos NV (Euronext: GLPG) (NASDAQ: GLPG) and Ryvu Therapeutics S.A. (WSE: RVU) today announced a collaboration focused on the discovery and development of novel small molecule drugs in inflammation. ...
After its stock reached all-time highs in February, Galapagos (NASDAQ: GLPG) saw those gains disappear. Don't fret, though. The stock price is down less than 1% year to date -- a decrease many investors, and companies, can only dream of in the current environment. Is Galapagos's lack of pri...
Source: New York Times Gilead ( GILD ) is working with regulatory authorities to provide expanded access to remdesivir, which is being offered to coronavirus patients: Gilead Sciences ((GILD)) has been working with regulatory authorities to start additional expanded access prog...
Following up on its initial announcements in January and February , Incyte (NASDAQ: INCY ) reports detailed results from two successful Phase 3 clinical trials, TRuE-AD1 and TRuE-AD2 , evaluating a topical cream formulation of kinase inhibitor ruxolitinib in adolescents and adults wi...
BioSig Technologies (NASDAQ: BSGM ) initiated with Buy rating and $9 (75% upside) price target at Roth Capital. More news on: BioSig Technologies, Inc., Amgen Inc., Cerner Corporation, Healthcare stocks news, Stocks on the move, , Read more ...
Osmotica Pharmaceuticals (NASDAQ: OSMT ) initiated with Buy rating and $8 (74% upside) price target at SunTrust. More news on: Osmotica Pharmaceuticals plc, Epizyme, Inc., Baxter International Inc., Healthcare stocks news, Stocks on the move, , Read more ...
February 2020 was a very volatile month for the stock market. As the number of Coronavirus cases increased exponentially outside of China, investors started to worry about its financial impact on the worldwide economy. As a consequence, the S&P 500 dropped by 11.23% with the strongest on...
There is a lot of uncertainty in the market that the number of Coronavirus cases will keep increasing exponentially. This could cost tens of thousands of peoples' lives and would impact the worldwide economy, which was already poor . Although the real consequences are still unclear, it will c...
News, Short Squeeze, Breakout and More Instantly...
2024-07-11 21:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Adaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next-generation MAGE-A4 TCR T-cell therapy) produced on Galapagos' decentralized manufacturing platform in patients with head & neck cancer Uza-cel has shown encouraging resul...